Paul Friese

3.2k total citations · 1 hit paper
35 papers, 2.6k citations indexed

About

Paul Friese is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Paul Friese has authored 35 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology and Allergy. Recurrent topics in Paul Friese's work include Platelet Disorders and Treatments (29 papers), Blood properties and coagulation (11 papers) and Cell Adhesion Molecules Research (7 papers). Paul Friese is often cited by papers focused on Platelet Disorders and Treatments (29 papers), Blood properties and coagulation (11 papers) and Cell Adhesion Molecules Research (7 papers). Paul Friese collaborates with scholars based in United States, France and Japan. Paul Friese's co-authors include George L. Dale, Samuel A. Burstein, Concetta T. Ammollo, Naomi L. Esmon, James H. Morrissey, Charles T. Esmon, Fabrizio Semeraro, Hideo Kimura, Toshiyuki Ishibashi and S Kariyone and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Paul Friese

34 papers receiving 2.5k citations

Hit Papers

Extracellular histones pr... 2011 2026 2016 2021 2011 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Friese United States 22 1.4k 770 487 457 345 35 2.6k
Jun Mimuro Japan 29 1.3k 1.0× 442 0.6× 840 1.7× 583 1.3× 286 0.8× 113 3.2k
Junji Nishioka Japan 31 1.7k 1.3× 345 0.4× 533 1.1× 342 0.7× 219 0.6× 99 3.0k
Patrizia Marchese United States 24 1.3k 0.9× 397 0.5× 444 0.9× 307 0.7× 177 0.5× 36 2.3k
Hansjörg Schwertz United States 26 1.2k 0.9× 617 0.8× 909 1.9× 317 0.7× 381 1.1× 50 2.8k
Raymond R. Schleef United States 29 1.3k 0.9× 318 0.4× 620 1.3× 606 1.3× 128 0.4× 57 2.7k
Seiji Madoiwa Japan 24 864 0.6× 429 0.6× 632 1.3× 269 0.6× 249 0.7× 92 2.5k
Jesse W. Rowley United States 26 1.1k 0.8× 904 1.2× 1.1k 2.2× 354 0.8× 548 1.6× 55 3.3k
Samuel A. Burstein United States 23 1.4k 1.0× 326 0.4× 454 0.9× 358 0.8× 341 1.0× 37 2.1k
J.J. Emeis Netherlands 21 1.1k 0.8× 308 0.4× 549 1.1× 386 0.8× 156 0.5× 51 2.4k
Dominique Meyer France 35 2.8k 2.0× 788 1.0× 533 1.1× 415 0.9× 192 0.6× 106 3.9k

Countries citing papers authored by Paul Friese

Since Specialization
Citations

This map shows the geographic impact of Paul Friese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Friese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Friese more than expected).

Fields of papers citing papers by Paul Friese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Friese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Friese. The network helps show where Paul Friese may publish in the future.

Co-authorship network of co-authors of Paul Friese

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Friese. A scholar is included among the top collaborators of Paul Friese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Friese. Paul Friese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Semeraro, Fabrizio, Concetta T. Ammollo, James H. Morrissey, et al.. (2011). Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood. 118(7). 1952–1961. 676 indexed citations breakdown →
2.
Dale, George L., et al.. (2009). Tetraspanin CD9 is required for microparticle release from coated-platelets. Platelets. 20(6). 361–366. 16 indexed citations
3.
Dale, George L. & Paul Friese. (2006). Bax activators potentiate coated‐platelet formation. Journal of Thrombosis and Haemostasis. 4(12). 2664–2669. 39 indexed citations
4.
Maroney, Susan A., Sandra L. Haberichter, Paul Friese, et al.. (2006). Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood. 109(5). 1931–1937. 98 indexed citations
5.
Dale, George L., et al.. (2005). Quantitation of microparticles released from coated‐platelets. Journal of Thrombosis and Haemostasis. 3(9). 2081–2088. 51 indexed citations
6.
Szász, Róbert, et al.. (2005). Role of Mitochondrial Permeability Transition Pore in Coated-Platelet Formation. Arteriosclerosis Thrombosis and Vascular Biology. 25(2). 467–471. 106 indexed citations
7.
Alberio, Lorenzo, Paul Friese, KJ Clemetson, & George L. Dale. (2002). Collagen Response and Glycoprotein VI Function Decline Progressively as Canine Platelets Age in vivo. Thrombosis and Haemostasis. 88(9). 510–516. 21 indexed citations
8.
Dale, George L., Paul Friese, Péter Batár, et al.. (2002). Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature. 415(6868). 175–179. 247 indexed citations
9.
Burstein, Samuel A., Anne Dubart‐Kupperschmitt, Françoise Norol, et al.. (1999). Expression of a foreign protein in human megakaryocytes and platelets by retrovirally mediated gene transfer. Experimental Hematology. 27(1). 110–116. 8 indexed citations
10.
Harrison, Paul, et al.. (1996). Inhibition of the acute-phase response in vivo by anti-gp130 monoclonal antibodies.. PubMed. 95(3). 443–51. 9 indexed citations
11.
Burstein, Samuel A., Paul Friese, Roman F. Wolf, et al.. (1996). Cytokine–Induced Alteration of Platelet and Hemostatic Function. Stem Cells. 14(S1). 154–162. 57 indexed citations
12.
Friese, Paul, et al.. (1994). Alteration of platelet function in dogs mediated by interleukin-6. Blood. 83(2). 398–403. 50 indexed citations
13.
Heilmann, E, et al.. (1994). Dog platelets accumulate intracellular Fibrinogen as they age. Journal of Cellular Physiology. 161(1). 23–30. 18 indexed citations
14.
Friese, Paul, et al.. (1994). Alteration of platelet function in dogs mediated by interleukin-6. Blood. 83(2). 398–403. 1 indexed citations
15.
Heilmann, E, Paul Friese, Stacy Anderson, et al.. (1993). Biotinylated platelets: a new approach to the measurement of platelet life span. British Journal of Haematology. 85(4). 729–735. 62 indexed citations
16.
Burstein, Samuel A., et al.. (1992). Leukemia inhibitory factor and interleukin‐11 promote maturation of murine and human megakaryocytes in vitro. Journal of Cellular Physiology. 153(2). 305–312. 126 indexed citations
17.
Kanz, Lothar, et al.. (1990). Analysis of megakaryocyte ploidy in patients with thrombocytosis. The International Journal Of Cell Cloning. 8(4). 299–306. 13 indexed citations
18.
Kimura, Hideo, et al.. (1990). Interleukin 6 is a differentiation factor for human megakaryocytes in vitro. European Journal of Immunology. 20(9). 1927–1931. 55 indexed citations
19.
Tomer, Aaron, et al.. (1990). Flow cytometric analysis of megakaryocytes (Mks) from patients with platelet disorders.. Progress in clinical and biological research. 356. 303–17. 1 indexed citations
20.
Ishibashi, Toshiyuki, Hideo Kimura, Tsuyoshi Uchida, et al.. (1989). Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.. Proceedings of the National Academy of Sciences. 86(15). 5953–5957. 362 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026